文献速递胸部肿瘤放疗放疗物理与技术

基于知识库的计划模型在RTOG 0617入组患者中的多机构验证:对协作组试验计划质量控制的意义

Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials.
PubMed 文献 · Pract Radiat Oncol · 2018-12-15

本研究利用单机构基于知识库的计划(KBP)模型对RTOG 0617试验中3家机构25例患者的计划进行回顾性再计划,评估其作为多机构临床试验剂量学质控工具的可行性。结果显示KBP生成计划在多数剂量学终点上优于临床试验计划,并能正确识别肺CTV V20Gy>37%的患者。

要点

  • 单机构KBP模型可用于多机构临床试验的剂量学质控,改善计划质量。
  • KBP模型能正确识别肺CTV V20Gy>37%的患者(25例中5例)。
  • 采用肺保护优化目标可显著降低肺CTV剂量。

核心结论

  • 单机构KBP模型可作为多机构临床试验的质控工具,改善整体计划质量并为确定基于解剖的剂量学权衡提供决策支持。

研究设计与样本

  • 回顾性评估,使用商业软件(RapidPlan;Varian Medical Systems)基于单机构106例非小细胞肺癌患者的KBP模型。
  • 3家向RTOG 0617提交大量临床计划的机构提供了25例患者数据,使用两套优化目标(优先靶区覆盖和优先肺保护)进行再计划。

主要发现

  • 与临床试验计划相比,多数KBP生成计划的靶区覆盖和危及器官保护显著改善。
  • 使用优先靶区覆盖目标的KBP模型使心脏Dmean和V40Gy分别降低2.1 Gy和5.2%。
  • 使用肺保护目标使肺CTV Dmean和V20Gy分别降低2.0 Gy和2.9%。
  • KBP预测正确识别了所有肺CTV V20Gy>37%的患者(25例中5例),应用肺保护优化目标后显著降低了肺CTV剂量。

关键数值与推荐

  • 计划处方范围为60 Gy/30次至74 Gy/37次,遵循RTOG 0617计划指南。
  • 剂量学终点采用RTOG 0617定义的终点。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to evaluate the feasibility of using a single-institution, knowledge-based planning (KBP) model as a dosimetric plan quality control (QC) for multi-institutional clinical trials. The efficacy of this QC tool was retrospectively evaluated using a subset of plans submitted to Radiation Therapy Oncology Group (RTOG) study 0617. METHODS AND MATERIALS: A single KBP model was created using commercially available software (RapidPlan; Varian Medical Systems, Palo Alto, CA) and data from 106 patients with non-small cell lung cancer who were treated at a single institution. All plans had prescriptions that ranged from 60 Gy in 30 fractions to 74 Gy in 37 fractions and followed the planning guidelines from RTOG 0617. Two sets of optimization objectives were created to produce different trade-offs using the single KBP model predictions: one prioritizing target coverage and a second prioritizing lung sparing (LS) while allowing an acceptable variation in target coverage. Three institutions submitted a high volume of clinical plans to RTOG 0617 and provided data on 25 patients, which were replanned using both sets of optimization objectives. Model-generated, dose-volume histogram predictions were used to identify patients who exceeded the lung clinical target volume (CTV) V20Gy >37% and would benefit from the LS objectives. Overall plan quality differences between KBP-generated plans and clinical plans were evaluated at RTOG 0617-defined dosimetric endpoints. RESULTS: Target coverage and organ at risk sparing was significantly improved for most KBP-generated plans compared with those from clinical trial data. The KBP model using prioritized target coverage objectives reduced heart Dmean and V40Gy by 2.1 Gy and 5.2%, respectively. Similarly, using LS objectives reduced the lung CTV Dmean and V20Gy by 2.0 Gy and 2.9%, respectively. The KBP predictions correctly identified all patients with lung CTV V20Gy > 37% (5 of 25 patients) and significantly reduced the dose to the lung CTV by applying the LS optimization objectives. CONCLUSIONS: A single-institution KBP model can be applied as a QC tool for multi-institutional clinical trials to improve overall plan quality and provide decision-support to determine the need for anatomy-based dosimetric trade-offs.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Kavanaugh JA, Holler S, DeWees TA, et al. Multi-Institutional Validation of a Knowledge-Based Planning Model for Patients Enrolled in RTOG 0617: Implications for Plan Quality Controls in Cooperative Group Trials. Pract Radiat Oncol. 2018. PMID: 30562615. doi:10.1016/j.prro.2018.11.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。